Research and analysis

Regenerative medicine in the UK: taking stock

Assesses the state of the regenerative medicine field internationally and analyses the UK’s strengths, weaknesses and areas of opportunity. …

From:
Department for Business, Innovation & Skills
Published
18 July 2011

Documents

Taking stock of regenerative medicine in the United Kingdom.

Ref: 11/1056

PDF, 1.27 MB, 58 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email enquiries@beis.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Assesses the state of the regenerative medicine field internationally and analyses the UK’s strengths, weaknesses and areas of opportunity. Identifies key barriers to the therapeutic and commercial use of regenerative medicines and sets out how government will work to overcome them. Aims to provide a strong evidence base for the government to coordinate funding decisions, and to lay the ground-work for an agreed strategy for regenerative medicine. See also reports on bibliometric analysis (URN 11/1059) and the patent landscape (11/1087).

Published 18 July 2011